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Ibuprofen controlled-release 
Scheme 2: Interaction of Ibuprofen with malonamide PMOs (top) 
and methylated malonamide (bottom): Above hydrophobic-phobic 
interactions, conjugation gives rise to ionic interactions, a H-
bonding interaction is lacking for mMA materials. 
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±1650 cm-1: Amide I (C=O) 
±1550 cm-1: Amide II (N-H) 
Sample MA (mmol/g) 
MA5 0,45 
MA10 0,93 
MA20 1,34 
MA30 1,86 
MA40 2,28 
mMA10 0,92 
Sample SBET (m2/g) Vp (mL/g) dp (nm) 
MA5 545 0,82 6,8 
MA10 341 0,53 5,2 
MA20 276 0,41 5,0 
MA30 176 0,26 / 
MA40 102 0,22 / 
mMA10 621 0,91 6,8 
Fig. 1: DRIFT spectra of (m)MA-PMOs with 
different functional loading. For clarity the 
intensity of (A), region of organic 
functionality, is enhanced compared to (B), 
region of Si-O stretch. Amide vibrations 
(highlighted) and C-H stretch (ν ~ 2950 
cm-1) confirm the presence of (m)MA 
moieties in the PMO-materials. 
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Scheme 1: Schotten-Baumann reaction of (3-aminopropyltriethoxy)silane 2a and (N-methyl 3-aminopropyltrimethoxy)silane 2b with 
malonylchloride 1. Next, the novel silsesquioxane PMO precursors are used to obtain an extensive range of 2D hexagonal PMOs with 
different functional loading by co-condensation with tetraethyl orthosilicate (TEOS) in a typical PMO synthesis (acidic medium, P123, 
KCl).  
Synthesis and analysis of (methyl)malonamide-PMOs 
Controlled drug release gained a sharply increasing interest over recent years. Multiple materials have been screened as possible drug carriers, ranging from biodegradable polymers 
to hydroxyapatite[1]. Periodic Mesoporous Organosilicas are valuable alternatives as they possess a high chemical and thermal stability combined with a biocompatible nature[2]. 
Furthermore, their large internal surface area permits a high drug loading. Careful selection of the organic ‘bridged’ functionality allows a controlled release with respect to external 
stimuli, such as pH or temperature, of the drugs which are adsorbed via weak and reversible interactions, e.g. H-bonding, ionic and hydrophobic-phobic interaction[3]. In this 
contribution a novel malonamide (MA-PMO) and a methyl-malonamide PMO (mMA-PMO) bearing a high amount of functionalities, capable of multiple intramolecular interactions, 
are developed and thoroughly characterized[4]. Subsequently, these hybrid materials are evaluated in the controlled drug release of Ibuprofen. 
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Fig. 2: XRD patterns 
showing P6mm 2D 
hexagonal ordering 
fo r MA5, MA10, 
MA20 and mMA10. 
This ordering is lost 
for MA30 and MA40. 
F i g .  3 :  S E M 
images of (A) MA5 
and (B) MA20. 
Respectively rod-
like and irregular 
shaped particles 
with similar size 
are found 
Ibuprofen adsorption 
Table 3: Ibuprofen loading at adsorption 
equilibrium (qe) in mgIBU/g of MA-PMO and 
corrected for the surface area (SBET) in mgIBU/m2.  
New, well-ordered (methyl-) malonamide-type PMOs are developed, showing high porosity and large pore sizes. A malonamide PMO (MA-PMO) is shown promising for controlled 
drug release as the high functional loading leads to large Ibuprofen adsorption. As the functional loading of the drug carrying PMO is increased, intrinsically more Ibuprofen is 
adsorbed. Furthermore, high amounts of drug are released in a controlled, linear fashion over a long timespan in a phosphate buffer solution (pH 7.4) at body temperature. Most 
interestingly, the rate of drug release is tunable by varying the malonamide functional loading. Intramolecular ionic interactions, through conjugation of the amide moieties and 
deprotonation of Ibuprofen at pH 7.4, are believed to be the major contribution of this delayed release. H-bonding in MA-PMOs gives rise to a longer retention of Ibuprofen 
compared to methyl-malonamide PMOs (mMA-PMOs). The combination of these possible interactions makes these new drug carriers widely applicable, e.g. in the controlled 
release of 5-fluorouracil (5-FU), an anti-cancer agent, or they can even be used as a combined pH-triggered release system of both IBU and 5-FU [5]. 
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Table 2: Surface area (SBET), total pore volume 
(Vp) and pore size (dp) of (m)MA-PMOs. dp for 
MA30 and MA40 is indeterminable due to lack of 
ordering. 
Fig. 4: N2 sorption isotherm of a typical MA-PMO 
(MA10) with pore size distribution (inset). H1 type 
IV hysteresis is clearly distinguished.  
PBS - pH 7.4 - 37°C Fig. 5: Ibuprofen 
release profiles of 
IBU-MA5 and IBU-
MA20. Cont ro l l ed 
drug release was 
found during a long 
period (10-12h), with 
high amounts of IBU 
released. A lower 
drug release rate is 
observed for higher 
M A - f u n c t i o n a l 
loading, which implies 
a tunable release 
ra te . The l onger 
retention of IBU in 
the MA20-PMO can 
be ascribed to more 
interactions between 
IBU and the PMO 
drug carrier. A 10% 
mMA shows the same 
release profi le as 
MA5. 
Tunable drug release rate by varying 
malonamide functional loading 
Recent work: 100% allylic PMO 
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Sample qe (mgIBU/g) qe (mgIBU/m2) 
SBA-15 103,06 0,159 
MA5 109,75 0,201 
MA10 81,28 0,238 
MA20 83,95 0,303 
mMA10 150,11 0,241 
